Terms: = Kidney tumors AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15
1 results:
1. Sorafenib is a potent inhibitor of fip1l1-PDGFRalpha and the imatinib-resistant fip1l1-PDGFRalpha T674I mutant.
Lierman E; Folens C; Stover EH; Mentens N; Van Miegroet H; Scheers W; Boogaerts M; Vandenberghe P; Marynen P; Cools J
Blood; 2006 Aug; 108(4):1374-6. PubMed ID: 16645167
[TBL] [Abstract] [Full Text] [Related]
